Whitehawk Therapeutics (3350.STU) Q2 2026 Earnings

7MayConfirmed
Q2 2026
-0.3
-0.29
-0.28
-0.27

Details

Expected EPS
-0.304829525
Actual EPS
-0.2728544
Surprise EPS
0.03
Surprise Percent
+10.49%

Description

Whitehawk Therapeutics (3350.STU) has reported earnings of -0.2728544 per share for Q2 2026.

0 Comments

Share your thoughts